In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria.

Antimicrobial Agents and Chemotherapy
R Fernández-RoblasJ Esteban

Abstract

We evaluated the in vitro activities of tigecycline and 10 other antibiotics against clinical isolates of nonpigmented rapidly growing mycobacteria. Fifteen collection strains and 165 clinical isolates were included in the study. Tigecycline showed the highest activity among all antibiotics studied: all the strains were inhibited by 1 mg/liter.

References

Dec 22, 1999·Antimicrobial Agents and Chemotherapy·R Fernández-RoblasF Soriano
Jul 18, 2000·Antimicrobial Agents and Chemotherapy·H W BoucherG M Eliopoulos
Feb 22, 2001·Antimicrobial Agents and Chemotherapy·R J WallaceR W Wilson
Oct 5, 2002·Clinical Microbiology Reviews·Barbara A Brown-Elliott, Richard J Wallace
May 23, 2003·Antimicrobial Agents and Chemotherapy·Shun-Cheng YangKwen-Tay Luh
Jul 26, 2005·The Journal of Antimicrobial Chemotherapy·George A Pankey
May 18, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mary A De Groote, Gwen Huitt
May 7, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J EstebanUNKNOWN Madrid Study Group of Mycobacteria

❮ Previous
Next ❯

Citations

Nov 16, 2010·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Yi-Ching HuangZhi-Yuan Shi
May 16, 2012·Antimicrobial Agents and Chemotherapy·Michael CynamonTrudy H Grossman
Jul 6, 2012·Clinical Microbiology Reviews·Barbara A Brown-ElliottRichard J Wallace
Jun 24, 2011·Journal of Clinical Microbiology·Chen-Hsiang LeeJien-Wei Liu
Apr 24, 2012·Expert Opinion on Pharmacotherapy·Jaime EstebanFernando Alcaide
Nov 26, 2009·Expert Opinion on Pharmacotherapy·Jaime Esteban, Alberto Ortiz-Pérez
Jan 26, 2010·Enfermedades infecciosas y microbiología clínica·Diego Vicente, Emilio Pérez-Trallero
Aug 15, 2013·Journal of Cardiac Surgery·Shinya UnaiHitoshi Hirose
May 3, 2012·Transplant Infectious Disease : an Official Journal of the Transplantation Society·H M BiggsC R Wolfe
Jan 28, 2010·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·S DormanUNKNOWN AST Infectious Diseases Community of Practice
Feb 7, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S S TangL Y Hsu
Aug 25, 2016·Microbial Pathogenesis·Vanessa da Costa FloresMarli Matiko Anraku de Campos
Mar 24, 2020·Expert Opinion on Pharmacotherapy·Maria-Carmen Muñoz-EgeaJaime Esteban
Nov 20, 2019·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Omaira Da Mata-JardínJacobus H de Waard
Dec 9, 2020·Antimicrobial Agents and Chemotherapy·Barbara A Brown-Elliott, Richard J Wallace
Apr 14, 2021·Indian Journal of Medical Microbiology·Megha SharmaShreya Khandelwal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.